Generation of immune checkpoint knock-out human antigen-specific T cells via CRISPR/Cas9-mediated genetic engineering

被引：0
|
作者：
Zhang, C. [1 ]
Peng, Y. [1 ]
Hublitz, P. [1 ]
Dong, T. [1 ]
机构：
[1] Univ Oxford, Weatherall Inst Mol Med WIMM, Nuffield Dept Med, Oxford, England
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
30
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CRISPR/Cas9-Mediated Knockout of DGK Improves Anti-Tumor Activities of Human T Cells
    Kim, Yoon-Young
    Jung, In-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Lee, Jungmin
    MOLECULAR THERAPY, 2018, 26 (05) : 55 - 55
  • [42] Generation of Monosomy 21q Human iPS Cells by CRISPR/Cas9-Mediated Interstitial Megabase Deletion
    Egawa, Masaya
    Uno, Narumi
    Komazaki, Rina
    Ohkame, Yusuke
    Yamazaki, Kyotaro
    Yoshimatsu, Chihiro
    Ishizu, Yuki
    Okano, Yusaku
    Miyamoto, Hitomaru
    Osaki, Mitsuhiko
    Suzuki, Teruhiko
    Hosomichi, Kazuyoshi
    Aizawa, Yasunori
    Kazuki, Yasuhiro
    Tomizuka, Kazuma
    GENES TO CELLS, 2025, 30 (01)
  • [43] Combining CRISPR/Cas9-mediated knockout with genetic complementation for in-depth mechanistic studies in human ES cells
    Wang, Zheng
    Zhang, Yan
    Lee, Yu-Wei
    Ivanova, Natalia B.
    BIOTECHNIQUES, 2019, 66 (01) : 23 - 27
  • [44] Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells
    Kaeuferle, Theresa
    Stief, Tanja A.
    Canzar, Stefan
    Kutlu, Nayad N.
    Willier, Semjon
    Stenger, Dana
    Ferrada-Ernst, Paulina
    Habjan, Nicola
    Peters, Annika E.
    Busch, Dirk H.
    Feuchtinger, Tobias
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)
  • [45] Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
    Suchy, Tomas
    Kaczmarek, Isabell
    Maricic, Tomislav
    Zieschang, Christian
    Schoeneberg, Torsten
    Thor, Doreen
    Liebscher, Ines
    ADIPOCYTE, 2021, 10 (01) : 631 - 645
  • [46] CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
    Khadijeh Alishah
    Matthias Birtel
    Elham Masoumi
    Leila Jafarzadeh
    Hamid Reza Mirzaee
    Jamshid Hadjati
    Ralf-Holger Voss
    Mustafa Diken
    Sedighe Asad
    Journal of Translational Medicine, 19
  • [47] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Rupp, Levi J.
    Schumann, Kathrin
    Roybal, Kole T.
    Gate, Rachel E.
    Ye, Chun J.
    Lim, Wendell A.
    Marson, Alexander
    SCIENTIFIC REPORTS, 2017, 7
  • [48] CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells
    Jung, In-Young
    Kim, Yoon-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Thon, Jonathan N.
    Lee, Jungmin
    BLOOD, 2017, 130
  • [49] CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
    Alishah, Khadijeh
    Birtel, Matthias
    Masoumi, Elham
    Jafarzadeh, Leila
    Mirzaee, Hamid Reza
    Hadjati, Jamshid
    Voss, Ralf-Holger
    Diken, Mustafa
    Asad, Sedighe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [50] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Levi J. Rupp
    Kathrin Schumann
    Kole T. Roybal
    Rachel E. Gate
    Chun J. Ye
    Wendell A. Lim
    Alexander Marson
    Scientific Reports, 7
12345